Verbal fluency may be a clinically relevant marker of cognitive dysfunction in multiple sclerosis and neuromyelitis optica spectrum disorders. Routine testing may help identify patients who could benefit from targeted cognitive rehabilitation interventions.
Grigoriadis et al. (Tue,) studied this question.